MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

12 Feb 2024 Evaluate
The sales for the December 2023 quarter moved down to Rs. 127.06 millions as compared to Rs. 134.20 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 721.12% to Rs. 13.22  millions  from Rs. 1.61 millions in previous same quarter.The company reported a good operating profit of 64.08 millions compared to 49.45 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 127.06 134.20 -5.32 333.30 372.21 -10.45 516.22 513.91 0.45
Other Income 0.30 0.09 233.33 0.30 0.16 87.50 0.36 0.92 -60.87
PBIDT 64.08 49.45 29.59 157.84 143.96 9.64 215.23 159.08 35.30
Interest 22.22 20.84 6.62 62.60 56.38 11.03 76.51 39.93 91.61
PBDT 41.86 28.61 46.31 95.24 87.58 8.75 138.72 119.15 16.42
Depreciation 22.76 23.03 -1.17 68.64 70.06 -2.03 92.66 74.41 24.53
PBT 19.10 5.58 242.29 26.60 17.52 51.83 46.06 44.74 2.95
TAX 5.88 3.97 48.11 8.36 11.57 -27.74 19.71 22.71 -13.21
Deferred Tax -0.09 3.02 -102.98 -1.11 8.64 -112.85 9.41 15.12 -37.76
PAT 13.22 1.61 721.12 18.24 5.95 206.55 26.35 22.03 19.61
Equity 149.04 148.77 0.18 149.04 148.77 0.18 149.03 142.64 4.48
PBIDTM(%) 50.43 36.85 36.87 47.36 38.68 22.44 41.69 30.95 34.69
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..